Is acupoint injection the optimal way to administer mecobalamin for diabetic peripheral neuropathy? A meta-analysis and trial sequential analysis

被引:1
|
作者
Zhang, Fei [1 ]
Yu, Yunfeng [1 ,2 ]
Yin, Shuang [1 ]
Hu, Gang [2 ]
Yang, Xinyu [1 ]
Tong, Keke [3 ]
Yu, Rong [2 ]
机构
[1] Hunan Univ Chinese Med, Coll Chinese Med, Changsha, Hunan, Peoples R China
[2] Hunan Univ Chinese Med, Hosp 1, Changsha, Hunan, Peoples R China
[3] Hosp Hunan Univ Tradit Chinese Med, Changde, Hunan, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
acupoint injection; mecobalamin; diabetes; peripheral neuropathy; systematic review; EFFICACY;
D O I
10.3389/fneur.2023.1186420
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Mecobalamin is a commonly used drug in the treatment of diabetic peripheral neuropathy (DPN). This study aimed to systematically evaluate the efficacy and safety of acupoint injection of mecobalamin for DPN.Methods Relevant clinical trials on acupoint injection of mecobalamin for DPN published before 31 January 2023 were searched in eight commonly used databases. After screening and confirming the included studies, meta-analysis and trial sequential analysis were performed.Results A total of 10 relevant studies were confirmed, and the total sample size was 927 cases. On the efficacy endpoints, meta-analysis showed that compared with other administration methods, acupoint injection of mecobalamin significantly increased the clinical effective rate by 27% [RR = 1.27, 95% CI = (1.19, 1.36), P < 0.00001], motor nerve conduction velocity (median nerve) by 5.93 m/s [MD = 5.93, 95% CI = (4.79, 7.07), P < 0.00001], motor nerve conduction velocity (common peroneal nerve) by 5.66 m/s [MD = 5.66, 95% CI = (2.89, 8.43), P < 0.0001], sensory nerve conduction velocity (median nerve) by 4.83 m/s [MD = 4.83, 95% CI = (3.75, 5.90), P < 0.00001], and sensory nerve conduction velocity (common peroneal nerve) by 3.60 m/s [MD = 3.60, 95% CI = (2.49, 4.71), P < 0.00001], and trial sequential analysis showed these benefits were conclusive. In terms of safety endpoints, meta-analysis indicated that the total adverse events for acupoint injection were comparable to other methods of administration, and trial sequential analysis suggested that the results needed to be validated by more studies. Subgroup analysis demonstrated that the benefits of acupoint injections of mecobalamin were not limited by the dose, duration of treatment, or number of acupoints reported in the included studies. Harbord's test showed no significant publication bias (P = 0.106).Conclusion The efficacy of acupoint injection of mecobalamin for DPN was significantly better than other administrations, and its safety was comparable to other administrations. Therefore, acupoint injection may be the optimal method of mecobalamin for DPN.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Tongxinluo-mecobalamin combination treatment is superior to mecobalamin alone for diabetic peripheral neuropathy: a meta-analysis
    Zhang, Fanghua
    Wang, Xia
    Yao, Minxiu
    Xu, Qian
    Xu, Aimei
    Wang, Huiling
    Gao, Shan
    Yan, Shengli
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 11382 - 11390
  • [2] Efficacy and safety of traditional Chinese medicine injection with mecobalamin in treating diabetic peripheral neuropathy A protocol for systematic review and meta-analysis
    Mai, Weihua
    Wei, Aisheng
    Lin, Xiaoxuan
    Wang, Funeng
    Ye, Jianhong
    Chen, Ping
    MEDICINE, 2021, 100 (01) : E23702
  • [3] Salviae miltiorrhizae and ligustrazine hydrochloride injection combined with mecobalamin for treating diabetic peripheral neuropathy A protocol for systematic review and meta-analysis
    Deng, Zhiyuan
    Wang, Manjia
    Fan, Yaohua
    Liu, Min
    MEDICINE, 2021, 100 (03) : E24103
  • [4] Genetics of diabetic neuropathy: Systematic review, meta-analysis and trial sequential analysis
    Zhao, Yating
    Zhu, Ruixia
    Wang, Danni
    Liu, Xu
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (10): : 1996 - 2013
  • [5] Combined Therapy of Diabetic Peripheral Neuropathy with Breviscapine and Mecobalamin: A Systematic Review and a Meta-Analysis of Chinese Studies
    Zheng, Chanjiao
    Ou, Weilin
    Shen, Huanyu
    Zhou, Zhiheng
    Wang, Jiaji
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [6] Effectiveness of acupuncture combined mecobalamin in the treatment of elderly diabetic peripheral neuropathy A protocol of systematic review and meta-analysis
    Duan, Yu-hong
    Liu, Ai-xia
    Su, Hong-xia
    Lv, Ji-hong
    Gong, Xue-ying
    Wang, Li
    MEDICINE, 2020, 99 (23)
  • [7] Effects of methylcobalamin on diabetic peripheral neuropathy: a meta-analysis of randomised controlled trial
    Li, Q.
    Wu, H.
    DIABETOLOGIA, 2018, 61 : S470 - S470
  • [8] Five Traditional Chinese Medicine External Treatment Methods Combined with Mecobalamin for Diabetic Peripheral Neuropathy: A Network Meta-Analysis
    Xu, Lijuan
    Zang, Deng
    Li, Hui
    Sulitang, Amanguli
    Li, Yinhui
    Ma, Jing
    Wang, Kai
    Ma, Li
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [9] The efficacy and safety of traditional Chinese medicine physiotherapy combined with acupoint injection on diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis
    Wang, Lin
    Guan, Bugao
    Li, Guangrun
    Feng, Liquan
    Sun, Hui
    Xu, Jin
    MEDICINE, 2022, 101 (50)
  • [10] The risk factors for diabetic peripheral neuropathy: A meta-analysis
    Liu, Xiuxiu
    Xu, Yuyan
    An, Miaomiao
    Zeng, Qibing
    PLOS ONE, 2019, 14 (02):